OncLive | Bringing the Global Oncology Community Together

Robert Coleman, MD, highlights recent advances made in gynecologic cancers and provide insight into ongoing research to move the needle forward. Read More >>

GI 2019: Durvalumab/Tremelimumab Combo Improves Efficacy in Refractory CRC

GI 2019: Single-Agent Durvalumab Elicits Responses in MSI-H CRC

GI 2019: Triplet Regimen Shows Durable Responses in BRAF V600E-Mutant Metastatic CRC

SGO WINTER 2019: Antiangiogenics, ADCs Still Have Roles in Ovarian Cancer Treatment

GI 2019: Regorafenib Extends PFS in Locally Advanced Biliary Tract Cancer

View More Stories >>

View Conference Coverage

2019 Transplantation and Cellular Therapy Meetings

2019 Winter Lung Cancer Conference

2019 SGO Winter Meeting

2019 Gastrointestinal Cancers Symposium

2018 State of the Science Summit on Advanced NSCLC

Dr. Leath Discusses Unmet Need in Cervical Cancer

Dr. Coleman on Advances Made in Ovarian Cancer Treatment

Dr. Llovet Discusses Second-Line Ramucirumab in Advanced HCC

Dr. Molena on Challenges With Endoscopic Resection in Esophageal Cancers

OncLive houses thousands of videos that provide updates and information.
See more Videos

Risk Assessment in Follicular Lymphoma

Diagnosis and Prognosis of Follicular Lymphoma

Considerations for Treating Patients with CDK4/6 Inhibitors

CDK4/6 Inhibitors in Metastatic Breast Cancer

Treating Newly Diagnosed High-Risk Smoldering Myeloma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Mantle Cell Lymphoma: Impact of Genetic Variants

Understanding the Heterogeneity of Mantle Cell Lymphoma

Progress in the Treatment of Multiple Myeloma

Glasdegib, Gilteritinib, and Quizartinib Against AML

Venetoclax for CLL After Progression on 1 Prior Therapy

Monoclonal Antibody, Triplet Therapy & Transplant Ineligible

Relapse Therapy: Incremental Change Versus Different Regimen

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

Expert Anticipates Cure in Acute Lymphoblastic Leukemia

Elias Jabbour, MD, discussed recent clinical trial results in acute lymphoblastic leukemia, the role of immunotherapy, and the biggest challenges facing the field.

View more >>>

Featured

Dr. Ramchandren on the North American Results of the ECHELON-1 Study in Hodgkin Lymphoma

Radhakrishnan Ramchandren MD, associate professor, Wayne State University School of Medicine, Barbara Ann Karmanos Cancer Institute, discusses the North American results of the ECHELON-1 study in Hodgkin lymphoma.

View more >>>